Thus, better identification of the underlying mechanism responsible for the pro-chemoresistance role of LGR6 in ovarian cancer will enhance our understanding for the chemoresistance in ovarian cancer, which will facilitate the development of novel therapeutic target against ovarian cancer. The gene discussed is LGR6; the disease is ovarian carcinoma.